Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
Device industry scrambles amid concern FDA layoffs will cause delays
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
Bluebird, at risk of default, agrees to take-private deal
*please scroll down for all the latest news*
